Eating on GLP-1 Medications vs Flexible Dieting (IIFYM)

Eating on GLP-1 MedicationsProtein-dense foods prioritized first at each meal (eggs, dairy, poultry, fish, tofu, legumes, protein supplements); smaller, more frequent meals; adequate fiber and fluids.

Flexible Dieting (IIFYM)Any foods that fit the day’s remaining macro and calorie targets — no specific food list.

Eating on GLP-1 MedicationsHigh-fat, greasy, or fried foods (they slow gastric emptying further and are a common nausea trigger); large meals in general.

Flexible Dieting (IIFYM)None categorically banned — the only requirement is hitting daily macro/calorie targets.

Eating on GLP-1 MedicationsSmaller, more frequent meals rather than a few large ones — recommended specifically to manage nausea from delayed gastric emptying, not a fixed window or schedule.

Flexible Dieting (IIFYM)No specific eating window — organized around daily macro/calorie totals, not timing.

Eating on GLP-1 MedicationsPreserve lean muscle mass and manage GI side effects while eating much less food overall.

Flexible Dieting (IIFYM)Hit daily protein/carb/fat and calorie targets with maximum food flexibility.

Eating on GLP-1 MedicationsPeople on GLP-1/GIP receptor agonist medications (semaglutide, tirzepatide, and similar) needing to close protein, fiber, and micronutrient gaps despite a much smaller appetite.

Flexible Dieting (IIFYM)People who do well with structure-light, numbers-based tracking and want the social and travel flexibility of no off-limits foods.

Eating on GLP-1 MedicationsHigh protein emphasis — 1.6–2.3 g protein per kg of fat-free mass daily (well above the 0.8 g/kg RDA), alongside resistance training.

Flexible Dieting (IIFYM)Defined entirely by protein/carb/fat gram targets and usually total calories — the core organizing principle of the diet.

Eating on GLP-1 MedicationsSpecifically for people on GLP-1/dual GIP-GLP-1 receptor agonist medications; addresses lean-mass loss (up to roughly 25% of weight lost is lean mass per SURMOUNT-1) and GI side effects (40–70% of patients).

Flexible Dieting (IIFYM)Research comparing flexible and rigid approaches to dietary restraint has generally linked flexible, non-black-and-white eating rules to lower rates of binge eating and disordered-eating symptoms than strict, all-or-nothing dieting, though findings aren't fully consistent across studies. The approach is also widely used in physique and bodybuilding contest prep, valued as a way to hit macro targets without the psychological rigidity of a fixed 'clean eating' list.

Eating on GLP-1 MedicationsStrong for the underlying mechanisms cited — DXA-based body-composition substudies (SURMOUNT-1, STEP 1) and clinical reviews, though the page notes a general lack of structured nutrition guidance for GLP-1 patients.

Flexible Dieting (IIFYM)Limited/indirect — no peer-reviewed study has evaluated “IIFYM” by that name; supporting evidence comes from the related but distinct “flexible vs. rigid dietary restraint” literature, mostly correlational, with one small RCT (n=23) on macro-based tracking.

Eating on GLP-1 MedicationsLow in food-type terms — no foods banned; the main constraint is a sharply reduced total food volume, which raises the risk of nutrient shortfalls.

Flexible Dieting (IIFYM)Low — no food is off-limits, but requires consistent daily tracking to work.

Eating on GLP-1 MedicationsPrioritizing protein-dense foods at every meal, and sometimes a protein supplement, to hit intake targets on a much smaller food volume can add cost on top of the medication itself.

Flexible Dieting (IIFYM)Flexible and affordable in principle since no specialty foods are required, though the diet says nothing about fiber, vitamins, minerals, or protein quality.